董诗洁, 胡晓欣, 王 葳, et al. Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model[J]. China Oncology, 2021, 31(6): 460-467.
董诗洁, 胡晓欣, 王 葳, et al. Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model[J]. China Oncology, 2021, 31(6): 460-467. DOI: 10.19401/j.cnki.1007-3639.2021.06.004.
Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model
Background and purpose: It is of great clinical value to search for early biomarkers that can be used to accurately evaluate lymph node metastasis before surgery. This study aimed to investigate the value of magnetic resonance imaging (MRI) omics parameters in predicting cervical cancer lymph node metastasis
and to establish and verify an imaging omics model for preoperative prediction of cervical cancer lymph node metastasis. Methods: The clinical data of 202 patients with non lymph node metastasis and lymph node metastasis of cervical cancer confirmed by postoperative pathological examination in Fudan University Shanghai Cancer Center from June 2015 to September 2019 were retrospectively analyzed. MRI images were selected as T2 weighted images (T2WI) and T1 contrast + (T1C+). Itk-snap software was used for three-dimensional manual segmentation of cervical cancer tumor regions. Through Pyradiomics
an open source Python package
and a Python programming platform Jupyter
imaging omics features were extracted through ten image type systems and 6 feature systems. Among a total of 202 patients with cervical cancer
104 had no lymph node metastasis
and 98 had lymph node metastasis. Imaging features were extracted from each patient in each group
including 1 923 features from the lymph node metastasis group and no lymph node metastasis group of T2WI sequence
1 923 features from the lymph node metastasis group and no lymph node metastasis group of T1C+ sequence
and 3 846 features from the lymph node metastasis group and no lymph node metastasis group of T2WI combined with T2WI-T1C+ sequence. Imaging omics label was established and validated by machine learning model. Finally
area under curve (AUC)
accuracy
positive predictive value (PPV) and negative predictive value (NPV) of the training set and the test set were used as the quantitative performance of the imaging omics label. Results: The T2WI sequence selected the features in the first 14 for classifier training
with the AUC of the training set=0.810 and the AUC of the test set =0.773. For T1C+ sequence
the first 16 features of feature sequencing were selected for classifier training
with AUC=0.819 in the training set and AUC=0.781 in the test set. In T2WI combined with T1C+sequence
the first 16 features of feature sequencing were selected for classifier training
with AUC=0.841 in the training set and AUC=0.803 in the test set. Conclusion: T2WI combined with T1C+ sequential imaging omics model has a good efficacy in predicting lymph node metastasis of early cervical cancer.
Research progress and prospects of MRI in predicting lymph node status in breast cancer
Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast
Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer
MRI-based radiomics and deep learning model construction: non-invasive differentiation of molecular subtypes in primary intracranial diffuse large B-cell lymphoma
A CT-based radiomics nomogram for predicting local tumor progression of colorectal cancer lung metastases treated with radiofrequency ablation
Related Author
Zihan ZHAI
Sheng CHEN
Qi LIU
Cai CHANG
Jiawei LI
Ruyu LIU
Chenyi WANG
Bo ZHANG
Related Institution
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Ultrasound Medicine, Fudan University Shanghai Cancer Center, Department of Medical Oncology, Shanghai Medical College, Fudan University
Japan Friendship Hospital (Institute of Clinical Medical Sciences), Peking Union Medical College, Chinese Academy of Medical Sciences,, China
Department of Ultrasound, China-Japan Friendship Hospital
National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital